Login to Your Account



Biosimilar MAbs Starting to Line up for Approval

By Sharon Kingman
Staff Writer

Tuesday, February 19, 2013
LONDON – 2013 will be a watershed year for biosimilars – biological therapies designed to be similar to existing biological therapeutic agents – delegates attending the Second Biosimilars Congregation in London heard Tuesday.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription